Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial.

Kannankeril PJ, Moore JP, Cerrone M, Priori SG, Kertesz NJ, Ro PS, Batra AS, Kaufman ES, Fairbrother DL, Saarel EV, Etheridge SP, Kanter RJ, Carboni MP, Dzurik MV, Fountain D, Chen H, Ely EW, Roden DM, Knollmann BC
JAMA Cardiol. 2017 2 (7): 759-766

PMID: 28492868 · PMCID: PMC5548393 · DOI:10.1001/jamacardio.2017.1320

MeSH Terms (17)

Adolescent Adrenergic beta-Antagonists Anti-Arrhythmia Agents Cross-Over Studies Death, Sudden, Cardiac Defibrillators, Implantable Drug Therapy, Combination Exercise Exercise Test Female Flecainide Humans Male Maximum Tolerated Dose Single-Blind Method Tachycardia, Ventricular Young Adult

Connections (1)

This publication is referenced by other Labnodes entities: